Capricor Therapeutics, Inc.

CAPR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$40-$22-$29-$20
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$10$7$4$3
Change in WC-$11-$12$29$0
Other Non-Cash$0-$0$0$0
Operating Cash Flow-$40-$26$5-$17
Investing Activities
PP&E Inv.-$2-$2-$3-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$208-$97-$114$0
Inv. Sales/Matur.$94$105$83$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$116$5-$35-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$152$26$5$20
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$153$26$5$20
Forex Effect$0$0$0$0
Net Chg. in Cash-$3$5-$25$2
Supplemental Information
Beg. Cash$15$10$35$33
End Cash$11$15$10$35
Free Cash Flow-$42-$28$2-$18
Capricor Therapeutics, Inc. (CAPR) Financial Statements & Key Stats | AlphaPilot